Search research articles
Contact Us
Filters
Showing results (211-220 of 256) with videos related to
Page
of 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma
Ryan D Cassaday, Oliver W Press, John M Pagel, et al.
Bone Marrow Transplantation
|
October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma
R N Pham, T A Gooley, G E Keeney, et al.
Animal : an International Journal of Animal Bioscience
|
June 7, 2021
Quantifying the frequency and volume of urine deposition by grazing sheep using tri-axial accelerometers
K A Marsden, L Lush, J A Holmberg, et al.
Transfusion
|
December 9, 2015
Detection of emergent strains of West Nile virus with a blood screening assay
Helen M Faddy, Robert L P Flower, Clive R Seed, et al.
Bone Marrow Transplantation
|
May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
D J Green, W I Bensinger, L A Holmberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2016
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma
Solomon A Graf, Jennifer E Vaughn, Thomas R Chauncey, et al.
Bone Marrow Transplantation
|
September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT
W I Bensinger, P S Becker, T A Gooley, et al.
American Journal of Hematology
|
April 4, 2020
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphoma
Victor A Chow, Joseph G Rajendran, Darrell R Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation
Lihua E Budde, Katherine A Guthrie, Brian G Till, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2018
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
Eileen P Smith, Hongli Li, Jonathan W Friedberg, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 256) with videos related to
Sort By:
Page
of 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma
Ryan D Cassaday, Oliver W Press, John M Pagel, et al.
Bone Marrow Transplantation
|
October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma
R N Pham, T A Gooley, G E Keeney, et al.
Animal : an International Journal of Animal Bioscience
|
June 7, 2021
Quantifying the frequency and volume of urine deposition by grazing sheep using tri-axial accelerometers
K A Marsden, L Lush, J A Holmberg, et al.
Transfusion
|
December 9, 2015
Detection of emergent strains of West Nile virus with a blood screening assay
Helen M Faddy, Robert L P Flower, Clive R Seed, et al.
Bone Marrow Transplantation
|
May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
D J Green, W I Bensinger, L A Holmberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2016
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma
Solomon A Graf, Jennifer E Vaughn, Thomas R Chauncey, et al.
Bone Marrow Transplantation
|
September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT
W I Bensinger, P S Becker, T A Gooley, et al.
American Journal of Hematology
|
April 4, 2020
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphoma
Victor A Chow, Joseph G Rajendran, Darrell R Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation
Lihua E Budde, Katherine A Guthrie, Brian G Till, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2018
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
Eileen P Smith, Hongli Li, Jonathan W Friedberg, et al.
Page
of 26